Clinical Trials in North Carolina

Showing 6441-6460 of 15,496 trials

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

NCT01334944

The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.

PainFever

Cumberland Pharmaceuticals150 participantsStarted Jun 2011

San Diego, California, United States • Danbury, Connecticut, United States • Miami, Florida, United States +10 more locations

COMPLETEDPhase 331 miles

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

NCT04406649

Study STS101-003 is a multi-center, multiple dose (PRN), open-label, 12-month study to evaluate the safety and tolerability of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

MigraineMigraine With AuraMigraine Without Aura

Satsuma Pharmaceuticals, Inc.482 participantsStarted Sep 2020

Encino, California, United States • Long Beach, California, United States • Los Alamitos, California, United States +41 more locations

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

Find Trials by Condition in North Carolina

Harvoni Treatment Porphyria Cutanea Tarda

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Dissemination and Implementation of Stroke Prevention Looking at the Care Environment

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes